A 58-year-old man from Delhi presents to the emergency department with fever (39.2°C), dysuria, and flank pain for 3 days. He has a history of recurrent urinary tract infections treated with multiple antibiotics over the past year. Urinalysis shows pyuria and bacteriuria. Urine culture grows a gram-negative rod. On antibiotic susceptibility testing, the organism is resistant to ceftriaxone and cefotaxime but susceptible to carbapenems and fluoroquinolones. The ESBL confirmatory test (double-disk synergy test) is positive. Which mechanism of resistance is most likely responsible for the cephalosporin resistance in this isolate?

Explanation

## Mechanism of ESBL-Mediated Resistance **Key Point:** ESBL (Extended-Spectrum Beta-Lactamase) is a beta-lactamase enzyme that hydrolyzes third-generation cephalosporins (ceftriaxone, cefotaxime, ceftazidime) and aztreonam, but is typically inhibited by beta-lactamase inhibitors like clavulanic acid. ### Clinical Clues in This Case 1. **Cephalosporin resistance pattern**: The organism is resistant to ceftriaxone and cefotaxime — the hallmark of ESBL-producing organisms. 2. **Carbapenem susceptibility**: Carbapenems remain active because they are poor substrates for most ESBLs and have strong PBP binding. 3. **Positive double-disk synergy test (DDST)**: This confirmatory test demonstrates synergy between cephalosporin and clavulanic acid, directly proving ESBL production. 4. **Fluoroquinolone susceptibility**: Suggests the resistance mechanism is enzymatic (ESBL), not related to altered PBPs or efflux pumps. ### ESBL Mechanism ESBLs are serine beta-lactamases (Class A) that: - Hydrolyze the beta-lactam ring of third-generation cephalosporins - Are inhibited by clavulanic acid, sulbactam, and tazobactam - Are NOT inhibited by cephamycins or carbapenems - Are typically plasmid-encoded and transferable between organisms **High-Yield:** The double-disk synergy test is the gold standard confirmatory test for ESBL detection — it shows enhanced inhibition zone when cephalosporin disk is placed near clavulanic acid disk. ### Differential Resistance Mechanisms | Mechanism | Cephalosporin | Carbapenem | Beta-lactamase Inhibitor Response | Confirmatory Test | |-----------|---------------|------------|-----------------------------------|-------------------| | ESBL | Resistant | Susceptible | Inhibited by clavulanic acid | DDST positive | | AmpC | Resistant | Susceptible | NOT inhibited | Cephamycin resistance | | Carbapenemase | Resistant | Resistant | Variable | Carbapenem MIC | | Altered PBPs | Resistant | Resistant | No response | Penicillin MIC | **Clinical Pearl:** In India, ESBL-producing Enterobacteriaceae (especially *E. coli* and *Klebsiella*) are increasingly common in community and hospital settings, particularly in patients with recurrent UTIs treated with multiple antibiotics. **Mnemonic: ESBL-DDST** — Extended-Spectrum Beta-Lactamase is confirmed by Double-Disk Synergy Test (cephalosporin + clavulanic acid).